Cargando…
CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells
HIV-1 is a major global health challenge. The development of an effective vaccine and a therapeutic cure are top priorities. The creation of vaccines that focus an antibody response toward a particular epitope of a protein has shown promise, but the genetic diversity of HIV-1 stymies this progress....
Autores principales: | Campbell, Grant R., Zhuang, Jia, Zhang, Gang, Landa, Igor, Kubiatowicz, Luke J., Dehaini, Diana, Fang, Ronnie H., Zhang, Liangfang, Spector, Stephen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419049/ https://www.ncbi.nlm.nih.gov/pubmed/34522224 http://dx.doi.org/10.7150/thno.59728 |
Ejemplares similares
-
Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
por: Zhao, Xiao-Yun, et al.
Publicado: (2020) -
SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages
por: Campbell, Grant R., et al.
Publicado: (2020) -
SMAC Mimetics as Therapeutic Agents in HIV Infection
por: Molyer, Bengisu, et al.
Publicado: (2021) -
Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1
por: Xie, Wei, et al.
Publicado: (2006) -
Role of Smac/DIABLO in cancer progression
por: Martinez-Ruiz, Gustavo, et al.
Publicado: (2008)